Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)
This study has been withdrawn prior to enrollment.
First Posted: June 11, 2012
Last Update Posted: April 8, 2013
Information provided by (Responsible Party):
Andrea Harzstark, University of California, San Francisco
No Study Results Posted on ClinicalTrials.gov for this Study
Study was withdrawn before participants were enrolled.
|Study Status:||This study has been withdrawn prior to enrollment.|
|Estimated Study Completion Date:||April 2016|
|Estimated Primary Completion Date:||December 2015 (Final data collection date for primary outcome measure)|